OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
30
Results
Show all
Save search
Copy query
Show results for
Unknown
(30)
Publication Date
Release Date
2018
(6)
2022
(4)
2019
(3)
2021
(2)
2016
(2)
2014
(2)
2013
(2)
2012
(2)
2010
(2)
2009
(2)
2024
(1)
2015
(1)
2011
(1)
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
Prospective International Randomized Phase II Study of Low-Dose Abiraterone With Food Versus Standard Dose Abiraterone In Castration-Resistant Prostate Cancer.
Not available
S-EPMC5941614
|
biostudies-literature
Cite
Comprehensive pharmacogenetic analysis of irinotecan neutropenia and pharmacokinetics.
Not available
S-EPMC2690389
|
biostudies-literature
Cite
ABC transporter polymorphisms are associated with irinotecan pharmacokinetics and neutropenia.
Not available
S-EPMC5432414
|
biostudies-literature
Cite
A randomized phase I trial of nanoparticle albumin-bound paclitaxel with or without mifepristone for advanced breast cancer.
Not available
S-EPMC4929099
|
biostudies-literature
Cite
In vitro and in vivo oxidative metabolism and glucuronidation of anastrozole.
Not available
S-EPMC3014069
|
biostudies-literature
Cite
Metabolism of megestrol acetate in vitro and the role of oxidative metabolites.
Not available
S-EPMC6129397
|
biostudies-literature
Cite
A phase I study of sirolimus and bevacizumab in patients with advanced malignancies.
Not available
S-EPMC4116678
|
biostudies-literature
Cite
Evidence for Clinical Implementation of Pharmacogenomics in Cardiac Drugs.
Not available
S-EPMC4475352
|
biostudies-literature
Cite
A genome-wide integrative study of microRNAs in human liver.
Not available
S-EPMC3710218
|
biostudies-literature
Cite
Establishment of CYP2D6 reference samples by multiple validated genotyping platforms.
Not available
S-EPMC4237721
|
biostudies-literature
Cite
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets